Janne Unkerskov

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

E. Hjardem, Mikkel Østergaard, Jan Pødenphant et al. · Annals of the Rheumatic Diseases · 2007 · 99 citations · Full text

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

Merete Lund Hetland, Hanne Lindegaard, Axel Kornerup Hansen et al. · Annals of the Rheumatic Diseases · 2008 · 77 citations

Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)

Merete Lund Hetland, Janne Unkerskov, Tine Ravn et al. · Scandinavian Journal of Rheumatology · 2005 · 44 citations

Causes of discrepancies between medications listed in the national electronic prescribing system and patients' actual use of medications

Cille Bülow, Josefine D. S. V. Noergaard, Kirstine Ullitz Færch et al. · Basic & Clinical Pharmacology & Toxicology · 2021 · 31 citations

Systematic Medication Review in General Practice by an Interdisciplinary Team: A thorough but Laborious Method to Address Polypharmacy among Elderly Patients

Dagmar Abelone Dalin, Charlotte Vermehren, Anette Kobberø Jensen et al. · Pharmacy · 2020 · 23 citations · Full text

Family Medicine, Pharmacotherapy, Drug Dispensing +19